https://www.novartis.com/se-se/
2024-01-22T12:30:48+00:00
daily
1.0
https://www.novartis.com/se-se/sidan-hittades-inte
2023-02-17T13:39:20+00:00
daily
1.0
https://www.novartis.com/se-se/karriar
2023-02-16T15:36:43+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/novartis-lofte-till-patienter-och-vardgivare
2024-02-14T08:52:54+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden
2023-09-20T08:28:05+01:00
daily
1.0
https://www.novartis.com/se-se/om-novartis/novartis-i-sverige
2023-11-07T14:06:46+00:00
daily
1.0
https://www.novartis.com/se-se/hallbarhet/etiska-principer
2023-02-15T09:33:38+00:00
daily
1.0
https://www.novartis.com/se-se/anvandarvillkor
2022-09-01T09:39:40+01:00
daily
1.0
https://www.novartis.com/se-se/integritetsskyddspolicies
2023-07-13T12:26:27+01:00
daily
1.0
https://www.novartis.com/se-se/cookies
2022-09-01T13:26:01+01:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/allergisk-astma
2023-02-15T06:39:34+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/kol
2023-02-15T06:50:57+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/tumorsjukdomar
2023-03-06T08:07:22+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/kliniska-studier
2024-01-08T10:29:20+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/brostcancer
2023-09-06T12:42:45+01:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/brostcancer/spridd-brostcancer
2023-03-06T07:56:56+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/nasselutslag-urtikaria
2023-02-15T07:02:50+00:00
daily
1.0
https://www.novartis.com/se-se/om-novartis/forskning-och-utveckling
2022-09-01T08:17:06+01:00
daily
1.0
https://www.novartis.com/se-se/om-novartis/vara-lakemedel
2023-10-04T08:46:28+01:00
daily
1.0
https://www.novartis.com/se-se/media/mediakontakt
2023-02-15T09:37:29+00:00
daily
1.0
https://www.novartis.com/se-se/aldersrelaterade-forandringar-i-gula-flacken-amd
2023-06-12T10:40:13+01:00
daily
1.0
https://www.novartis.com/se-se/blodpropp-i-ogat
2023-06-12T10:34:10+01:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/ms
2023-02-01T11:41:03+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/psoriasis
2023-02-28T14:44:04+00:00
daily
1.0
https://www.novartis.com/se-se/om-novartis/kontakta-oss
2023-11-30T14:20:18+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/hjartsvikt
2023-02-01T10:38:31+00:00
daily
1.0
https://www.novartis.com/se-se/om-novartis/ersattningar-till-svensk-halso-och-sjukvard
2023-07-10T07:25:19+01:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/ogonsjukdomar
2023-06-12T10:42:52+01:00
daily
1.0
https://www.novartis.com/se-se/diabetes-och-ogonsjukdom
2023-06-12T10:34:35+01:00
daily
1.0
https://www.novartis.com/se-se/gron-starr
2023-06-12T10:35:14+01:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/ogonsjukdomar/gra-starr-katarakt
2023-06-12T10:34:55+01:00
daily
1.0
https://www.novartis.com/se-se/torra-ogon
2023-06-12T10:35:29+01:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/psoriasisartrit
2023-02-28T14:45:18+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/axial-spondylartrit
2023-09-04T07:39:36+01:00
daily
1.0
https://www.novartis.com/se-se/community-guidelines-novartis-facebook-sidor
2023-03-05T20:18:39+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/migran
2023-02-15T06:54:16+00:00
daily
1.0
https://www.novartis.com/se-se/integritetsskyddspolicies/integritetsskyddspolicy-den-har-hemsidan
2022-09-05T07:14:00+01:00
daily
1.0
https://www.novartis.com/se-se/integritetsskyddspolicies/novartis-allman-integritetspolicy-affarspartner
2022-09-05T07:53:41+01:00
daily
1.0
https://www.novartis.com/se-se/integritetsskyddspolicies/novartis-general-privacy-notice-business-partners
2022-09-02T06:51:28+01:00
daily
1.0
https://www.novartis.com/se-se/novartis-meddelande-om-skydd-av-personuppgifter-facebook-sidor
2022-09-05T07:52:38+01:00
daily
1.0
https://www.novartis.com/se-se/integritetsskyddspolicies/sakerhetsovervakning-av-lakemedel-medicinsk-information-och-reklamationer
2023-02-10T08:57:56+00:00
daily
1.0
https://www.novartis.com/se-se/novartis-meddelande-om-skydd-av-personuppgifter-instagram-sidor
2022-09-02T09:29:05+01:00
daily
1.0
https://www.novartis.com/se-se/community-guidelines-novartis-instagram-sidor
2023-07-13T12:47:24+01:00
daily
1.0
https://www.novartis.com/se-se/novartis-meddelande-om-skydd-av-personuppgifter-linkedin-sidor
2022-09-05T08:02:14+01:00
daily
1.0
https://www.novartis.com/se-se/community-guidelines-novartis-linkedin-sidor
2023-07-13T12:46:36+01:00
daily
1.0
https://www.novartis.com/se-se/novartis-integritetspolicy-patienter
2022-09-05T07:36:42+01:00
daily
1.0
https://www.novartis.com/se-se/novartis-meddelande-om-skydd-av-personuppgifter-twitter-konto
2022-09-05T08:09:53+01:00
daily
1.0
https://www.novartis.com/se-se/community-guidelines-novartis-twitter
2022-09-01T11:47:05+01:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/malignt-melanom
2023-08-25T13:56:16+01:00
daily
1.0
https://www.novartis.com/se-se/privacy-notice-clinical-trial-site-personnel
2022-09-02T13:45:04+01:00
daily
1.0
https://www.novartis.com/se-se/novartis-allmant-integritetsmeddelande-offentliga-relationer
2022-09-06T10:20:22+01:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/immunologisk-trombocytopeni-itp
2023-02-02T08:20:56+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/myeloproliferativa-neoplasier
2023-03-06T13:44:35+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/polycytemia-vera
2023-03-06T13:44:00+00:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/retinitis-pigmentosa
2023-08-31T13:08:16+01:00
daily
1.0
https://www.novartis.com/se-se/karriar/hur-vi-arbetar
2023-02-15T09:47:38+00:00
daily
1.0
https://www.novartis.com/se-se/remodel-2-en-studie-dig-med-ms
2023-04-17T08:37:32+01:00
daily
1.0
https://www.novartis.com/se-se/patienter-och-vardgivare/behandlingsomraden/hidradenitis-suppurativa-hs
2023-09-20T07:02:11+01:00
daily
1.0
https://www.novartis.com/se-se/media
2023-02-15T09:36:36+00:00
daily
0.5
https://www.novartis.com/se-se/om-novartis
2023-02-20T08:37:28+00:00
daily
0.5
https://www.novartis.com/se-se/home
2024-01-22T12:30:48+00:00
daily
0.5
https://www.novartis.com/se-se/hallbarhet-archived
2023-02-20T13:02:33+00:00
daily
0.5
https://www.novartis.com/se-se/patienter-och-vardgivare
2023-06-06T12:01:58+01:00
daily
0.5
https://www.novartis.com/se-se/vardpersonal
2024-02-02T15:30:36+00:00
daily
0.5
https://www.novartis.com/se-se/stories/cell-och-genterapier-ar-vanligtvis-engangsbehandlingar
2024-01-22T12:20:18+00:00
daily
1.0
https://www.novartis.com/se-se/stories/cell-och-genterapitekniker-vad-ar-aav-car-t-och-crispr
2022-09-01T08:25:23+01:00
daily
1.0
https://www.novartis.com/se-se/stories/hur-skiljer-sig-cell-och-genterapier-fran-konventionella-terapier
2023-02-24T16:34:24+00:00
daily
1.0
https://www.novartis.com/se-se/stories/vad-ar-cell-och-genterapier
2022-09-01T07:21:19+01:00
daily
1.0
https://www.novartis.com/se-se/stories/patientriksdagen-2021
2022-09-05T08:05:33+01:00
daily
1.0
https://www.novartis.com/se-se/stories/patientriksdagen-2022
2023-02-13T09:33:06+00:00
daily
1.0
https://www.novartis.com/se-se/stories/patientriksdagen-utsedd-till-arets-live-event-i-sabre-awards
2023-03-24T09:11:41+00:00
daily
1.0
https://www.novartis.com/se-se/stories/novartis-ar-en-del-av-halso-och-sjukvarden
2024-01-22T14:53:53+00:00
daily
1.0